Finally, both PRMT6 and p62 are highly expressed in pancreatic cancer cells, resulting in the elevated PRMT6-mediated p62 AMDA, which greatly attenuates the efficiency of ferroptosis induction. This evidence concerns the gene PRMT6 and familial pancreatic carcinoma.